Balance Sheet for Leap Therapeutics Inc. (LPTX)

$ 1.96 0.00 (0.00%) Volume: 700 4:00 PM EDT 10-Jul-2020
Pre-Market:  $ 1.96 0.00 (0.00%) Volume: 700 8:23 AM EDT 13-Jul-2020
Statement: View:
Assets [+] in Thousands of Dollars
12/2019 12/2018 12/2017 12/2016 12/2015
Cash and Equivalents 3,891 16,284 25,737 793 405
Restrictable Cash - - - - -
Marketable Securities - - - - 6,607
Accounts Receivable 185 836 1,744 3,053 -
Loans Receivable - - - - -
Other Receivables 185 836 1,744 - -
Receivables 185 836 1,744 3,053 -
Inventories, Raw Materials - - - - -
Inventories, Work in Progress - - - - -
Inventories, Purchased Components - - - - -
Inventories, Finished Goods - - - - -
Inventories, Other - - - - -
Inventories, Adjustments & Allowances - - - - -
Inventories - - - - -
Prepaid Expenses 165 202 177 183 89
Current Deferred Income Taxes - - - - -
Other Current Assets - - - - -
Total Current Assets 4,241 17,322 27,658 4,029 494
Land and Improvements - - - - -
Buildings and Improvement 1,095 69 69 69 219
Machinery, Furniture and Equipment 194 139 139 75 511
Construction in Progress - - - - -
Fixed Assets, Other - - - - -
Fixed Assets, Total 1,289 208 208 144 730
Gross Fixed Assets 1,289 208 208 144 730
Accumulated Depreciation (139) (122) (73) (25) (498)
Net Fixed Assets 1,150 86 135 119 232
Intangibles - - - - 138
Cost in Excess - - - - -
Non-Current Deferred Income Taxes 127 124 158 - -
Other Non-Current Assets - 1,542 1,111 907 -
Total Non-Current Assets 3,207 1,752 1,404 2,428 766
Total Assets 7,448 19,074 29,062 6,457 1,260
Liabilities [+] in Thousands of Dollars
12/2019 12/2018 12/2017 12/2016 12/2015
Accounts Payable 4,571 3,579 2,622 3,225 2,048
Short Term Debt 474 - - 30,274 3,141
Notes Payable - - - - -
Accrued Expenses 3,441 2,872 3,461 2,633 479
Accrued Liabilities 3,441 2,872 3,461 2,633 479
Deferred Revenues - - - - -
Current Deferred Income Taxes - - - - -
Other Current Liabilities - - - 25 -
Total Current Liabilities 8,486 6,451 6,083 36,157 5,668
Long Term Debt N/A N/A N/A - -
Deferred Income Tax - - - - -
Other Non-Current Liabilities 159 3,448 11,862 - -
Minority Interest - - - - -
Capital Lease Obligations 552 - - - -
Preferred Securities of Subsidiary Trust - - - - -
Preferred Equity Outside Shareholders' Equity - - - 70,531 65,881
Total Non-Current Liabilities 711 3,448 11,862 70,531 65,881
Total Liabilities 9,197 9,899 17,945 106,688 71,549
Preferred Shareholder's Equity - - - - -
Common Shareholder's Equity (1,749) 9,175 11,117 (100,231) (70,289)
Common Par 24 15 12 - -
Additional Paid in Capital 193,319 162,393 141,770 145 100
Cumulative Translation Adjustments - - - - -
Retained Earnings (195,168) (153,535) (130,397) (100,670) (70,388)
Treasury Stock - - - - -
Other Equity Adjustments 76 302 (268) 294 (1)
Total Capitalization (1,749) 9,175 11,117 (100,231) (70,289)
Total Equity (1,749) 9,175 11,117 (100,231) (70,289)
Total Liabilities & Shareholder's Equity 7,448 19,074 29,062 6,457 1,260
Cash Flow (32,900) (23,138) (29,971) (25,632) (21,103)
Working Capital (4,245) 10,871 21,575 (32,128) (5,174)
Free Cash Flow (27,002) (26,033) (22,201) (25,481) (19,592)
Invested Capital (1,749) 9,175 11,117 (100,231) (70,289)
Shares Outstanding - Common Class Only 24,195 14,703 12,354 17,081 17,058
Preferred Shares Outstanding - - - - -
Total Ordinary Shares 24,195 14,703 12,354 17,058 17,058
Total Common Shares Outstanding 24,195 14,703 12,354 17,081 17,058
Treasury Shares - - - - -
Basic Weighted Shares Outstanding 22,583 14,144 9,162 9,392 18,248
Diluted Weighted Shares Outstanding 22,583 14,413 9,189 9,392 18,248